Monitoring Therapeutic Interventions in Critically Ill Septic Patients

Abstract

Sepsis is the leading cause of admission to intensive care units in the United States. Although the treatment of sepsis is complex and multimodal, nutrition support plays an important role in the management of these patients. The diagnosis of sepsis, disease category, and severity of illness and the change in sepsis severity and organ function over time affect the delivery of nutrition support. This paper reviews the diagnostic criteria of sepsis, the use of “sepsis biomarkers,” and regional and global markers of organ function in sepsis and quantitative measures of illness severity and organ dysfunction.

Get full access to this article

View all access options for this article.

References

Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546– 1554.

Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med. 2001 ;29:1303– 1310.

Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med. 1998 ;26:2078– 2086.

Marik PE, Varon J. Sepsis: state of the art. Dis Mon. 2001;47:463– 532.

Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699– 709.

Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002 ;288:862– 871.

Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest. 2002 ;122:1784– 1796.

Hart BB, Stanford GG, Ziegler MG, Lake CR, Chernow B. Catecholamines: study of interspecies variation. Crit Care Med. 1989;17:1203– 1218.

van den Berghe G. Neuroendocrine pathobiology of chronic illness. Crit Care Clin. 2002 ;18:509– 528.

10.

Siegel JH, Cerra FB, Coleman B, et al. Physiological and metabolic correlations in human sepsis: invited commentary. Surgery. 1979;86:163– 193.

11.

Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodualtion in sepsis. Intensive Care Med. 2004 ;30:748– 756.

12.

Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999 ;27:1807– 1813.

13.

Gadek JE, DeMichele SJ, Karlstad MD et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome: Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999 ;27:1409– 1420.

14.

Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med. 1999 ;27:1369– 1377.

15.

Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990's: systemic inflammatory response and organ dysfunction. JAMA. 1994;271:226– 233.

16.

Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med. 1996;24:1072– 1078.

17.

Thijs LG. Peripheral circulation in human septic shock. Intensive Crit Care Digest. 1988 ;7:9– 11.

18.

Ince C. The microcirculation unveiled. Am J Respir Crit Care Med. 2002;166:1– 4.

19.

Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest. 1994;94:2077– 2083.

20.

Piper RD, Pitt-Hyde M, Li F, Sibbald W, Potter RF. Microcirculatory changes in rat skeletal muscle in sepsis. Am J Respir Crit Care Med. 1996;154:931– 937.

21.

Cryer HM, Garrison RN, Harris PD. Role of muscle microvasculature during hyperdynamic and hypodynamic phases of endotoxin shock in decerebrate rats. J Trauma. 1988 ;28:312– 318.

22.

Baker CH, Davis DL. Endotoxin effects on capillary transit times of RBC and plasma as measured by indicator dilution. Microvasc Res. 1980;20:242– 252.

23.

Winslow C, Dorinsky PM. Regional blood flow distribution in endotoxin-treated dogs: modification by ibuprofen. J Crit Care. 1994;9:159– 168.

24.

Fink MP, Cohn SM, Lee P, et al. Effect of lipopolysaccharide on intestinal intramucosal hydrogen ion concentration in pigs: evidence of gut ischemia in a normodynamic model of septic shock. Crit Care Med. 1989;17:641– 646.

25.

Booke M, Hinder F, McGuire R, Traber LD, Traber DL. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med. 1996 ;24:835– 844.

26.

Brooke M, Hinder F, McGuire R, Traber LD, Traber DL. Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow. Shock. 1996 ;5:362– 370.

27.

Vallet B, Lund N, Curtis SE, Kelly D, Cain SM. Gut and muscle P02 in endotoxemic dogs during shock and resuscitation. J Appl Physiol. 1994;76:793– 800.

28.

Whitworth PW, Cryer HM, Garrison RN, Baumgarten TE, Harris PD. Hypoperfusion of the intestinal microcirculation without decreased cardiac output during live Escherichia coli sepsis in rats. Circ Shock. 1989;27:111– 122.

29.

Pastores SM, Katz DP, Kvetan V. Splanchnic ischemia and gut mucosal injury in sepsis and the multiple organ dysfunction syndrome. Am J Gastroenterol. 1996;91:1697– 1710.

30.

Nelson D, Beyer C, Samsel R, Wood LDH, Schumacker PT. Pathologic supply dependence of systemic and intestinal O₂ uptake during bacteremia in the dog. J Appl Physiol. 1987 ;63:1487– 1489.

31.

Doig CJ, Sutherland LR, Sandham JS, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patiens. Am J Respir Crit Care Med. 1998;158:444– 451.

32.

De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002 ;166:98– 104.

33.

Creteur J, De Backer D, Sakr Y, Vincent JL. Sublingual PCO₂ monitoring in patients with septic shock [abstract]. Crit Care Med. 2003 ;30:A19 .

34.

Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology. 1997 ;113:1246– 1257.

35.

Fink MP. Cytopathic hypoxia: mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin. 2001;17:219– 237.

36.

Fink MP. Bench-to-bedside review: cytopathic hypoxia. Crit Care. 2002;6:491– 499.

37.

Fink MP. Cytopathic hypoxia: is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? Crit Care Clin. 2002 ;18:165– 175.

38.

Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med. 1995 ;98:75– 84.

39.

Zeller WP, The SM, Sweet M, et al. Altered glucose transporter in mRNA abundance in a rat model of endotoxic shock. Biochem Biophys Res Commun. 1991;176:535– 540.

40.

Hotchkiss RS, Karl IE. Reevaluation of the role of cellular hypoxia and bioenergetics failure in sepsis. JAMA. 1992 ;267:1503– 1510.

41.

Wasan KM, Lopex-Berestein G. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch Med Res. 1993 ;24:395– 401.

42.

Marik PE. Gastric intramucosal pH: a better predictor of multiorgan dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest. 1993 ;104:225– 229.

43.

Levy B, Bollaert PE, Charpentier C, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized, study. Intensive Care Med. 1997 ;23:282– 287.

44.

Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg. 1996 ;224:97– 102.

45.

Marik PE, Bankov A. Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients. Crit Care Med. 2003;31:818– 822.

46.

Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368– 1377.

47.

Astiz ME, Rackow EC, Kaufman B, Falk JL, Weil MH. Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med. 1988;16:655– 658.

48.

Mahutte CK, Jaffe MB, Sasse SA, et al. Relationship of thermodilution cardiac output to metabolic measurements and mixed venous oxygen saturation. Chest. 1993 ;104:1236– 1242.

49.

Vaughn S, Puri VK. Cardiac output changes and continuous mixed venous oxygen saturation measurement in the critically ill. Crit Care Med. 1988;16:495– 498.

50.

Marik PE, Varon J. The hemodynamic derangements in sepsis: implications for treatment strategies. Chest. 1998 ;114:854– 860.

51.

Marik PE. Sublingual capnography: a clinical validation study. Chest. 2001;120:923– 927.

52.

Dantzker DR. The gastrointestinal tract: the canary of the body? JAMA. 1993;270:1247– 1248.

53.

Fink MP. Tissue capnometry as a monitoring strategy for critically ill patients: just about ready for prime time. Chest. 1998 ; 114:667– 670.

54.

Gutierrez G, Brown SD. Gastrointestinal tonometry: a monitor of regional dysoxia. New Horiz. 1996 ;4:413– 419.

55.

Sato Y, Weil MH, Tang W. Tissue hypercarbic acidosis as a marker of acute circulatory failure (shock). Chest. 1998 ;114:263– 274.

56.

Weil MH, Nakagawa Y, Tang W, et al. Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med. 1999 ;27:1225– 1229.

57.

Marik P. Gastric tonometry: the canary sings once again. Crit Care Med. 1998 ;26:809– 810.

58.

Krebs HA, Woods HF, Alberti KGMM. Hyperlactatemia and lactic acidosis. Essays Med Biochem. 1970 ;1:81– 103.

59.

Grum CM, Fiddian-Green RG, Pittenger GL, et al. Adequacy of tissue oxygenation in intact dog intestine. J Appl Physiol. 1984 ;56:1065– 1069.

60.

Schlichtig R, Bowles SA. Distinguishing between aerobic and anaerobic appearance of dissolved CO₂ in intestine during low flow. J Appl Physiol. 1994 ;76:2443– 2451.

61.

Guzman JA, Kruse JA. Development and validation of a technique for continuous monitoring of gastric intramucosal pH. Am J Respir Crit Care Med. 1996;153:694– 700.

62.

Salzman AL, Wang H, Wollert PS, et al. Endotoxin-induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis. Am J Physiol. 1994;266:G633– G646.

63.

Dubin A, Murias G, Estenssoro E, et al. Intramucosal-arterial PCO₂ gap fails to reflect intestinal dysoxia in hypoxic hypoxia. Crit Care. 2002;6:514– 520.

64.

Neviere R, Chagnon JL, Teboul JL, Vallet B, Wattel F. Small intestine intramucosal PCO₂ and microvascular blood flow during hypoxic and ischemic hypoxia. Crit Care Med. 2002 ;30:379– 384.

65.

Antonsson JB, Boyle CC, Kruithoff KL, et al. Validation of tonometric measurement of gut intramucosal pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol. 1990 ; 259:G519– G523.

66.

Montgomery AM, Hartmann K, Jonsson K, Haglund U. Intramucosal pH measurement with tonometers for detecting gastrointestinal ischemia in porcine hemorrhagic shock. Circ Shock. 1989 ;29:319– 327.

67.

Schlichtig R, Mehta N, Gayowski TJP. Tissue-arterial PCO₂ difference is a better marker of ischemia than intramucosal pH (pHi) or arterial pH-pHi difference. J Crit Care. 1996 ;11:51– 56.

68.

Elizalde JI, Hernández C, Lach J, et al. Gastric intramucosal acidosis in mechanically ventilated patients: role of mucosal blood flow. Crit Care Med. 1998 ;26:827– 833.

69.

Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993;270:1203– 1210.

70.

Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med. 1995 ;23:1184– 1193.

71.

Ivatury RR, Simon RJ, Islam S, et al. A prospective randomized study of end points of resuscitation after major trauma: global oxygen transport indices versus organ-specific gastric mucosal pH. J Am Coll Surg. 1996;183:145– 154.

72.

Gutierrez G, Palizas F, Doglio G, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet. 1992;339:195– 199.

73.

Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995 ;130:423– 429.

74.

Pernat A, Weil MH, Tang W, et al. Effects of hyper- and hypoventilation on gastric and sublingual PCO₂. J Appl Physiol. 1999;87:933– 937.

75.

Nakagawa Y, Weil MH, Tang W, et al. Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med. 1998;157:1838– 1843.

76.

Povoas HP, Weil MH, Tang W, et al. Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest. 2000 ;118:1127– 1132.

77.

Wu SG, Lin SL, Shiao WY, et al. Comparison of sublingual captopril, nifedipine and prazosin in hypertensive emergencies during hemodialysis. Nephron. 1993;65:284– 287.

78.

Engoren M. Lack of association between atelectasis and fever. Chest. 1995;107:81– 84.

79.

El Desoky AE, Seifalian AM, Davidson BR. Effect of graded hypoxia on hepatic tissue oxygenation measured by near infrared spectroscopy. J Hepatol. 1999 ;31:71– 76.

80.

Guery BP, Mangalaboyi J, Menager P, et al. Redox status of cytochrome a,a3: a noninvasive indicator of dysoxia in regional hypoxic or ischemic hypoxia. Crit Care Med. 1999 ;27:576– 582.

81.

Seifalian AM, El Desoky H, Delpy DT, Davidson BR. Effect of graded hypoxia on the rat hepatic tissue oxygenation and energy metabolism monitored by near-infrared and 31P nuclear magnetic resonance spectroscopy. FASEB J. 2001;15:2642– 2648.

82.

Webster's Ninth New Collegiate Dictionary. Springfield, MA: Merriam-Webster, Inc; 1991.

83.

Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864– 874.

84.

Abraham E, Matthay MA, Dinarello CA, et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med. 2000;28:232– 235.

85.

Cohen J, Guyatt G, Bernard GR, et al. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med. 2001;29:880– 886.

86.

Zahorec R. Definitions for the septic syndrome should be re-evaluated [letter]. Intensive Care Med. 2000 ;26:1870 .

87.

Aouifi A, Piriou V, Bastien O, et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000;28:3171– 3176.

88.

Herget-Rosenthal S, Marggraf G, Pietruck F, et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant. 2001;16:975– 979.

89.

Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med. 1999 ;27:2172– 2176.

90.

Suprin E, Camus C, Gacouin A, et al. Procalcitonin: a valuable indicator of infection in a medical ICU? Intensive Care Med. 2000;26:1232– 1238.

91.

Selberg O, Hector H, Martin M, et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med. 2000 ;28:2793– 2798.

92.

Muller B, Becker KL, Schachinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000 ;28:977– 983.

93.

de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med. 1997 ;25:607– 613.

94.

Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999 ;27:498– 504.

95.

Wanner G, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med. 2000 ; 28:950– 957.

96.

Sachse C, Machens HG, Felmerer G, Berger A, Henkel E. Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. J Burn Care Rehabil. 1999 ;20:354– 360.

97.

Rau B, Steinbach G, Gansauge F, et al. The potential role of procalcitonin and interleukin-8 in the prediction of infected necrosis in acute pancreatitis. Gut. 1997 ;41:832– 840.

98.

Mandi Y, Farkas G, Takacs T, Boda K, Lonovics J. Diagnostic relevance of procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis in acute pancreatitis. Int J Pancreat. 2000 ;28:41– 49.

99.

Enguix A, Rey C, Concha A, et al. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med. 2001;27:211– 215.

100.

Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr. 1996;128:570– 573.

101.

Chiesa C, Panero A, Rossi N, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998 ;26:664– 672.

102.

Assicot M, Grendel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;34:515– 518.

103.

Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med. 2002;28:1351– 1356.

104.

Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 2002 ;28:1220– 1225.

105.

Reny JL, Vaaauagnat A, Ract C, et al. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared to other clinical and biological variables. Crit Care Med. 2002;30:529– 535.

106.

Miller PR, Munn DD, Meredith JW, Chang MC. Systemic inflammatory response syndrome in the trauma intensive care unit: who is infected? J Trauma. 1999;47:1004– 1008.

107.

Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesions molecules, C-reactive protein in preterm very low birthweight infants. Arch Dis Chil Fetal Neontal Ed. 1997;77:F221– F227.

108.

Al Nawas B, Frammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res. 1996 ;1:331– 333.

109.

Gramm HJ, Hannemann L. Activity markers for the inflammatory host response and early criteria of sepsis. Clin Intensive Care. 1996;7(Suppl 1):1– 3.

110.

Povoa P, Almeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998 ;24:1052– 1056.

111.

Marik PE. The diagnosis of sepsis: not quite ready to dump SIRS? Crit Care Med. 2002 ;30:706– 708.

112.

Brunkhorst FM, Al Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect. 2002 ;8:93– 100.

113.

Guven H, Altintop L, Baydin A, et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med. 2002;20:202– 206.

114.

Riche FC, Cholley BP, Laisne MJ, et al. Inflammatory cytokines, C reactive protein, and procalcitonin as early predictors of necrosis infection in acute necrotizing pancreatitis. Surgery. 2003 ;133:257– 262.

115.

Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737– 1741.

116.

Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;164:396– 402.

117.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985 ;13:818– 828.

118.

Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991 ;100:1619– 1636.

119.

Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993 ;270:2957– 2963.

120.

Lemeshow S, Teres D, Klar J, et al. Mortality prediction models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270:2478– 2486.

121.

Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988 ;16:1110– 1116.

122.

Marik PE, Varon J. Severity scoring and outcome assessment: computerized predictive models and scoring systems. Crit Care Clin. 1999;15:633– 646.

123.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg. 1985 ;202:685– 672.

124.

Bone RC. Sepsis, the sepsis syndrome, multiorgan failure: a plea for comparable definitions. Ann Intern Med. 1991 ;114:332– 333.

125.

Berrtleff MJOE, Bruining HA. How should multiple organ dysfunction syndrome be assessed? A review of the variations in current scoring systems. Eur J Surg. 1997 ;163:405– 409.

126.

Vincent JL, Moreno R, Takala J, et al, on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996 ;22:707– 710.

127.

Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995 ;23:1638– 1652.